DRKS00021426招募中不适用
Prodromal Alpha-Synuclein Screening in Parkinson’s Disease Study - PASS-PD
niversitätsklinikum Schleswig-Holstein Campus Kiel0 个研究点目标入组 2,000 人开始时间: 2020年12月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 50 Years 至 99 Years（—）
- 性别
- All
入选标准
- •(I) Capacity for consent (in case of doubt verified by two independent neurologists), (II) written informed consent, (III) age = 50 years
排除标准
- •(I) Presence of clinical PD at the time of study inclusion, (II) other significant neurologic diseases affecting the central nervous system (e.g. Multiple sclerosis), (III) other significant diseases e.g. orthopaedic diseases affecting quantitative motor assessment; (IV) in case of participation in the lumbal puncture substudy: contraindications for the performance of lumbal puncture (bleeding tendency, intake of anticoagulants)
研究者
相似试验
已完成
不适用
Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.Parkinsonian DisordersParkinson DiseaseNCT01380899Universidad Autonoma de San Luis Potosí87
招募中
不适用
Prodromal Alpha-Synuclein Screening in Parkinson's Disease StudyParkinson DiseaseNCT04724941University Hospital Schleswig-Holstein2,000
已完成
不适用
Synuclein-One StudyDementia With Lewy BodiesPure Autonomic FailureParkinson DiseaseMultiple System AtrophyNCT04700722CND Life Sciences428
已完成
不适用
Biological Markers in Parkinson's DiseaseParkinson DiseaseNCT00088335National Institute of Neurological Disorders and Stroke (NINDS)90
进行中（未招募）
不适用
Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's DiseaseREM Behavior DisorderParkinson DiseaseNCT06621602CND Life Sciences100